Identification of inhibitors for the transmembrane Trypanosoma cruzi eIF2α kinase relevant for parasite proliferation
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Tiago de Paula Marcelino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Parasites, Chagas Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
The TcK2 protein kinase of Trypanosoma cruzi, the causative agent of Chagas disease, is structurally similar to the human kinase PERK, which phosphorylates the initiation factor eIF2α and, in turn, inhibits translation initiation. We have previously shown that absence of TcK2 kinase impairs parasite proliferation within mammalian cells, positioning it as a potential target for treatment of Chagas disease. To better understand its role in the parasite, here we initially confirmed the importance of TcK2 in parasite proliferation by generating CRISPR/Cas9 TcK2-null cells, albeit they more efficiently differentiate into infective forms. Proteomics indicates that the TcK2 knockout of proliferative forms expresses proteins including trans-sialidases, normally restricted to infective and nonproliferative trypomastigotes explaining decreased proliferation and better differentiation. TcK2 knockout cells lost phosphorylation of eukaryotic initiation factor 3 and cyclic AMP responsive-like element, recognized to promote growth, likely explaining both decreased proliferation and augmented differentiation. To identify specific inhibitors, a library of 379 kinase inhibitors was screened by differential scanning fluorimetry using a recombinant TcK2 encompassing the kinase domain and selected molecules were tested for kinase inhibition. Only Dasatinib and PF-477736, inhibitors of Src/Abl and ChK1 kinases, showed inhibitory activity with IC50 of 0.2 ± 0.02 mM and 0.8 ± 0.1, respectively. In infected cells Dasatinib inhibited growth of parental amastigotes (IC50 = 0.6 ± 0.2 mM) but not TcK2 of depleted parasites (IC50 > 34 mM) identifying Dasatinib as a potential lead for development of therapeutics for Chagas disease targeting TcK2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
- Center for Molecular Biology and Genetic Engineering - CBMEG, Center of Medicinal Chemistry - CQMED, Structural Genomics Consortium - SGC, University of Campinas - UNICAMP, Campinas, SP, Brazil.
- Center for Molecular Biology and Genetic Engineering - CBMEG, Center of Medicinal Chemistry - CQMED, Structural Genomics Consortium - SGC, University of Campinas - UNICAMP, Campinas, SP, Brazil; Departamento de Ciências…
- Drug Discovery and Evaluation Unit, Department of Parasitology, Faculty of Science, Charles University in Prague, BIOCEV, Vestec, Czech Republic.
- School of Life Sciences, University of Dundee, Dundee, UK.
- School of Life Sciences, University of Dundee, Dundee, UK; Biology Centre, Institute of Parasitology, Czech Academy of Sciences, Ceske Budejovice, Czech Republic.
Förderung
- Wellcome Trust
- Medical Research Council
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Newton Fund
- FAPESP
- Ministry of Education Youth and Sports of the Czech Republic
Zitieren
APA
Marcelino, T. P., Fala, A. M., da Silva, M. M., Souza-Melo, N., Malvezzi, A. M., Klippel, A. H., Zoltner, M., Padilla-Mejia, N., Kosto, S., Field, M. C., Burle-Caldas, G. A., Teixeira, S. M. R., Couñago, R. M., Massirer, K. B., & Schenkman, S. (2023). Identification of inhibitors for the transmembrane Trypanosoma cruzi eIF2α kinase relevant for parasite proliferation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104857
Vancouver
Marcelino TP, Fala AM, da Silva MM, Souza-Melo N, Malvezzi AM, Klippel AH, et al. Identification of inhibitors for the transmembrane Trypanosoma cruzi eIF2α kinase relevant for parasite proliferation. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104857
BibTeX
@article{Marcelino2023,
author = {Marcelino, Tiago de Paula and Fala, Angela Maria and da Silva, Matheus Monteiro and Souza-Melo, Normanda and Malvezzi, Amaranta Muniz and Klippel, Angélica Hollunder and Zoltner, Martin and Padilla-Mejia, Norma and Kosto, Samantha and Field, Mark C and Burle-Caldas, Gabriela de Assis and Teixeira, Santuza Maria Ribeiro and Couñago, Rafael Miguez and Massirer, Katlin Brauer and Schenkman, Sergio},
title = {Identification of inhibitors for the transmembrane Trypanosoma cruzi eIF2α kinase relevant for parasite proliferation},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104857}
}
EUVIMED